December 5, 2021

News

News Network

Malawi National Day

18 min read

Antony J. Blinken, Secretary of State

On behalf of the Government of the United States of America, it is my pleasure to congratulate the people of Malawi on the occasion of your National Day.  Our countries boast a partnership rooted in shared values and expressed through decades of close collaboration.

Now more than ever, Malawi stands as a beacon of democratic success and stability.  Malawian peacekeepers have risked their lives to help bring security and stability to conflicts across the continent.  People around the world look to Malawi as a society that has trusted, invested in, and benefited from the independence of its institutions.  Malawi will soon assume the chairmanship of the Southern African Development Community, and the region is sure to benefit from your commitment to these democratic ideals.

Today, we celebrate Malawi’s progress and its promise for the future.

More from: Antony J. Blinken, Secretary of State

News Network

  • Secretary Antony J. Blinken With Jon Delano of KDKA-TV Pittsburgh
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Compounding Pharmacy Mogul Sentenced for Multimillion-Dollar Health Care Fraud Scheme
    In Crime News
    A Mississippi businessman was sentenced today for his role in a multimillion-dollar scheme to defraud TRICARE, the health care benefit program serving U.S. military, veterans, and their respective family members, as well as private health care benefit programs.
    [Read More…]
  • Pakistan Independence Day  
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Secretary Antony J. Blinken at a Virtual Town Hall with U.S. Mission Nigeria and U.S. Embassy Nairobi Employees and Family Members
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Joint Statement on the Anniversary of Mr. Alexey Navalny’s Poisoning
    In Crime Control and Security News
    Office of the [Read More…]
  • Secretary Pompeo’s Meeting with Islamic Republic of Afghanistan’s Negotiating Team
    In Crime Control and Security News
    Office of the [Read More…]
  • Taxpayer Advocate Service: Opportunities Exist to Improve Reports to Congress
    In U.S GAO News
    What GAO Found The budget for the Internal Revenue Service's (IRS) Taxpayer Advocate Service (TAS) declined by about 14 percent from fiscal years 2011 to 2020, when adjusted for inflation. For fiscal year 2020, TAS used most of its resources to assist individual taxpayers, known as case advocacy. TAS allocated about 76 percent of its $222 million budget and 86 percent of its almost 1,700 full-time equivalents to this purpose. The percentage of resources for case advocacy has decreased during the past decade—in fiscal year 2011 about 85 percent of the budget was devoted to it. For the same period, resources to address broader issues affecting groups of taxpayers, known as systemic advocacy, increased from 9 percent to 14 percent of the total budget. This shift is due in part to the reallocation of staff to better integrate systemic advocacy work and TAS's overall attrition rate more than doubling to 15.9 percent between fiscal years 2011 and 2019. Since 2011, TAS has received more than 2 million taxpayer cases, of which almost half were referrals from other IRS offices. TAS closed more cases than it received each year from 2012 to 2017, but its inventory has grown since fiscal year 2018, due in part to attrition in case advocacy staff and an increase in taxpayers seeking assistance (see figure below). Number of Taxpayer Cases Received and Closed, Fiscal Years 2011 to 2020 TAS has recently modified its two mandated reports to Congress by reducing their length and separately compiling legislative recommendations. It shortened its annual reports in part because the Taxpayer First Act reduced the required number of most serious taxpayer problems from “at least 20” to “the 10” most serious problems. GAO identified the following additional actions that could further improve TAS reporting. Report outcome-oriented objectives and progress. The objectives for the upcoming fiscal year that TAS included in its most recent report are not always clearly identified and do not link to the various planned activities that are described. Further, the objectives TAS does identify do not include measurable outcomes. In addition, TAS's reports do not include the actual results achieved against objectives so it is not possible to assess related performance and progress. Improved performance reporting could help both TAS and Congress better understand which activities are contributing toward achieving TAS's objectives and where actions may be needed to address any unmet goals. Consult with Congress and other stakeholders. TAS briefs congressional committees each year after publishing its annual report and solicits perspectives from stakeholders. TAS officials said they incorporate the perspectives into its objectives. However, TAS does not follow leading practices to consult congressional committees about its goals and objectives prior to publication at least once every 2 years. Thus, it misses opportunities to obtain congressional input on its objectives and performance reporting. Consultations would provide TAS opportunities to confirm if its goals incorporate congressional and other stakeholder perspectives and whether its reports meet their information needs. Publish updates on recommendation implementation status. By law, TAS's annual report must include an inventory of actions IRS has fully, partially, and not yet taken on TAS's recommendations to address the most serious problems facing taxpayers. If those recommendations take multiple years to implement, which some have as shown in the table below, updating the inventory would be required. In its objectives reports, TAS provides only a one-time inventory of IRS responses to TAS's recommendations made during the preceding year, including plans and preliminary actions taken for those IRS accepts for implementation. TAS does not publicly update the inventory in subsequent annual reports to reflect actions IRS takes or does not take to address TAS's recommendations. This reporting approach does not provide complete information on the status of actions IRS has taken to address serious problems facing taxpayers and also does not provide the information in the annual report, as required. Publishing such updated status information would support congressional oversight. Taxpayer Advocate Service's (TAS) Recommendation Reporting and Status as of the Fourth Quarter of Fiscal Year 2020 GAO also identified options for TAS to consider to improve its reporting. These options include explaining changes to the list of the most serious taxpayer problems from year to year and streamlining report sections congressional staff use less frequently. Why GAO Did This Study TAS, an independent office within IRS, helps taxpayers resolve problems with IRS and addresses broader, systemic issues that affect groups of taxpayers by recommending administrative and legislative changes to mitigate such problems. Congress mandated that TAS issue two reports every year—one known as the annual report which includes sections on, among other things, the 10 most serious problems encountered by taxpayers, and the other known as the objectives report that discusses organizational objectives. GAO was asked to review how TAS carries out its mission, focusing on resources and reporting. This report (1) describes TAS's resources and workload, and (2) assesses TAS's reporting to Congress and identifies opportunities for improvement. GAO reviewed documents from TAS, IRS, and other sources, including TAS's annual and objectives reports and internal guidance; analyzed TAS's budget, staffing, and workload data for fiscal years 2011 through 2020; and interviewed knowledgeable TAS and IRS officials. GAO assessed TAS's reporting of its objectives and performance against statutory requirements, relevant internal control standards, and selected key practices for performance reporting developed by GAO. In addition, GAO reviewed relevant TAS web pages, analyzed the length and composition of TAS's reports, and interviewed key congressional committee staff to identify additional options to improve TAS's reporting.
    [Read More…]
  • On the Silencing and Prosecution of PRC Citizen Journalist Zhang Zhan
    In Crime Control and Security News
    Michael R. Pompeo, [Read More…]
  • Nepal Travel Advisory
    In Travel
    Reconsider travel [Read More…]
  • Veterans Health Care: VA’s Medical Support Role in Emergency Preparedness
    In U.S GAO News
    Since the terrorist attacks on September 11, 2001, the Department of Veterans Affairs (VA) has increased its efforts to plan for and respond to national emergencies, including acts of terrorism and natural disasters. Additionally, in August 2004, the Federal Bureau of Investigation and the Department of Homeland Security announced that military and VA medical facilities were potential terrorist targets. In light of military casualties from conflicts in Afghanistan and Iraq and continued threats of terrorist incidents, Congress asked us to review VA's medical support role in emergency preparedness. Specifically, we agreed to provide information on the following questions: (1) What is VA's role in providing medical support within the U.S. to military personnel in wartime and during national emergencies? (2) What actions has VA taken to improve its internal emergency preparedness to ensure that it is ready to maintain continuity of operations and provision of medical services to veterans? (3) What is VA's role in participating in emergency medical response measures with other federal, state, and local agencies?GAO found that Public Law 97-174 authorizes VA to provide inpatient medical care to active duty members of the armed services during or immediately following their involvement in armed conflicts during wartime and national emergencies. According to VA, while the Department of Defense (DOD) has never requested priority care from VA based on this law, VA has routinely reported to the Congress and DOD the number of inpatient beds available for military personnel. We also found that VA has taken numerous actions to improve emergency preparedness, such as developing educational and training materials for its staff, training staff at 134 VA medical centers, and increasing security at its facilities by requiring a minimum of two patrolling VA police officers on duty at all times. Other activities, such as developing a systemwide strategy for protecting its facilities and acquiring decontamination equipment, are still in progress. Finally, VA participates in emergency medical response measures with other federal, state, and local agencies by providing assistance in seven support functions outlined in the Department of Homeland Security's National Response Plan. For example, if requested, the types of support VA would provide include public health and medical services, emergency management, and public safety and security.
    [Read More…]
  • 2021 Australia-U.S. Ministerial Consultations
    In Crime Control and Security News
    Office of the [Read More…]
  • Drug Development: Pathway for Approving Antibacterial and Antifungal Drugs for Patients with Limited Treatment Options is Infrequently Used
    In U.S GAO News
    What GAO Found Antibacterial and antifungal infections resistant to available drugs are a serious public health challenge. However, the number of drugs under development may be insufficient to meet this threat, in part because developers face economic and other challenges in developing drugs for these conditions, many of which are still relatively rare. The Food and Drug Administration (FDA) may use a certain pathway—known as the limited population pathway for antibacterial and antifungal drugs (LPAD)—to approve drugs intended to treat serious or life-threatening infections that affect a limited group of patients and are not adequately addressed by available therapy. LPAD does not fundamentally change FDA's drug approval process, but it does provide tools that can help the agency accept greater risk and uncertainty when deciding to approve a drug for these otherwise difficult to treat infections, according to FDA officials. As a result, officials say FDA may approve a drug for a limited population because of the potential benefits for these patients, despite risks that would be unacceptable if the drug was intended to treat a broader population. GAO's review of FDA documentation shows that since LPAD was established in 2016, drug developers have formally requested approval under LPAD for four drugs, two of which were approved: Two Drugs Approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD), as of June 2021 Drug Name Condition approved to treat Population with condition Arikayce Treatment of a bacterial infection in the lung called refractory Mycobacterium avium complex lung disease Fewer than 27 per 100,000 persons older than 60 years of age Pretomanid Treatment of types of highly drug-resistant tuberculosis 123 cases reported in the United States in 2017 Source: Food and Drug Administration and Centers for Disease Control and Prevention. | GAO-22-105042 FDA and stakeholders agreed that LPAD's effect on the drug pipeline could be limited because the pathway does not address the economic challenges facing the development of these products. For example, according to stakeholders, given the limited market for such drugs, sales revenue can be insufficient to cover development costs, making it difficult for companies to survive in the antibacterial and antifungal drug market. In March 2020, GAO reported on similar challenges and recommended that the Department of Health and Human Services (HHS) develop a strategy to further incentivize the development of new treatments for antibiotic-resistant infections, including the use of post-market financial incentives, which could include rewards for market entry or reimbursement reform. HHS did not concur with this recommendation, and as of June 2021, the agency indicated that it was still examining the issue and this recommendation had not been implemented. Why GAO Did This Study It is estimated that at least 2.8 million antibacterial and antifungal-resistant infections occur each year in the United States, and more than 35,000 people die as a result, according to the Centers for Disease Control and Prevention. The development of new antibacterial and antifungal treatments is one strategy to address the threat of antimicrobial resistance. The 21st Century Cures Act, enacted in 2016, established LPAD to help facilitate the approval of certain antibacterial and antifungal drugs. FDA oversees the approval of such drugs. The 21st Century Cures Act includes a provision for GAO to review and report on FDA's LPAD activities. This report describes (1) the extent to which LPAD changes FDA's drug approval process, (2) the extent to which drug developers have sought to use LPAD for drugs under development, and (3) stakeholders' and FDA's views on the effectiveness of LPAD in benefiting the development and approval of antibacterial and antifungal drugs. GAO reviewed FDA guidance documents; documentation from the approval process; and drug developers' written statements to investors and FDA on LPAD. GAO also interviewed FDA officials and obtained information from 10 stakeholders selected because they sought approval for a drug through LPAD, considered using LPAD, or provided written comment to FDA on LPAD. These included two industry associations, one think tank, and seven drug developers. HHS provided technical comments on a draft of this report, which GAO incorporated as appropriate. For more information, contact Mary Denigan-Macauley at (202) 512-7114 or deniganmacauleym@gao.gov.
    [Read More…]
  • Domestic Renewal as a Foreign Policy Priority
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Secretary Antony J. Blinken And Ukrainian Foreign Minister Dmytro Kuleba Before Their Meeting
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Condemning Ethiopia’s Plans to Expel UN Officials
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Hospital Researcher Sentenced to Prison for Conspiring to Steal Trade Secrets and Sell to China
    In Crime News
    An Ohio man was sentenced yesterday to 33 months in prison for conspiring to steal exosome-related trade secrets concerning the research, identification and treatment of a range of pediatric medical conditions.
    [Read More…]
  • Secretary Antony J. Blinken and Mexican Secretary of Economy Tatiana Clouthier Before Their Meeting
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Secretary Antony J. Blinken And Saudi Foreign Minister Faisal bin Farhan Al Saud Before Their Meeting 
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Justice Department Settles Retaliation Claim Against Florida Electrician Company
    In Crime News
    The Justice Department today announced that it reached a settlement agreement with Service Minds Inc., dba Mister Sparky (Service Minds), a company that provides contract electrical services to residential customers in Florida and Alabama. The settlement resolves a claim that the company retaliated against a work-authorized job applicant, in violation of the anti-discrimination provision of the Immigration and Nationality Act (INA), when he and his wife challenged a U.S. citizens-only hiring rule that a recruiter had wrongly claimed was the company’s policy.
    [Read More…]
  • Lebanon Travel Advisory
    In Travel
    Reconsider travel [Read More…]
Network News © 2005 Area.Control.Network™ All rights reserved.